Merck KGaA Establishes New Beijing-based R&D Site To Drive Asia Research
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - German conglomerate Merck KGaA has launched a new research and development hub in Beijing as it seeks to satisfy growing demand for pharmaceutical products in China and Asia